Table 3. Medios AI-AMD diagnosis versus ophthalmologist diagnosis.
| AMD diagnosis | Medios AI-AMD for target device | |||
| Validation set | Test set | |||
| Non-referable AMD | Referable AMD | Non-referable AMD | Referable AMD | |
| Ophthalmologist grading* | ||||
| No AMD | 104 | 12 | 105 | 10 |
| Early AMD | 20 | 6 | 18 | 7 |
| Non-referable† | 12 | 5 | 10 | 8 |
| Intermediate | ||||
| AMD | 4 | 32 | 5 | 35 |
| Advanced AMD | 5 | 31 | † | 32 |
| Referable‡ | * | 6 | 0 | 6 |
| Diagnostic accuracy, % | ||||
| Recall No AMD | 89.66(95% CI: 82.6 to 94.5) | 91.30(95% CI: 84.6 to 95.8) | ||
| Recall Early AMD | 76.92(95% CI: 56.4 to 91.0) | 72.00(95% CI: 50.6 to 87.9) | ||
| Recall Intermediate AMD | 88.89(95% CI: 73.9 to 96.9) | 87.50(95% CI: 73.2 to 95.8) | ||
| Recall Advanced AMD | 86.11(95% CI: 70.5 to 95.3) | 94.12(95% CI: 80.3 to 99.3) | ||
Ground Ttruth.
No consensus, but 2two out 3three ophthalmologists graded non-referable.
No consensus, but 2two out 3three ophthalmologists graded referable.
AIartificial intelligenceAMDage-related macular degeneration